These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16084398)

  • 21. Probing secondary glutaminyl cyclase (QC) inhibitor interactions applying an in silico-modeling/site-directed mutagenesis approach: implications for drug development.
    Koch B; Buchholz M; Wermann M; Heiser U; Schilling S; Demuth HU
    Chem Biol Drug Des; 2012 Dec; 80(6):937-46. PubMed ID: 22967026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crystal structures of glutaminyl cyclases (QCs) from Drosophila melanogaster reveal active site conservation between insect and mammalian QCs.
    Koch B; Kolenko P; Buchholz M; Carrillo DR; Parthier C; Wermann M; Rahfeld JU; Reuter G; Schilling S; Stubbs MT; Demuth HU
    Biochemistry; 2012 Sep; 51(37):7383-92. PubMed ID: 22897232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of glutaminyl cyclase attenuates cell migration modulated by monocyte chemoattractant proteins.
    Chen YL; Huang KF; Kuo WC; Lo YC; Lee YM; Wang AH
    Biochem J; 2012 Mar; 442(2):403-12. PubMed ID: 22060158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glutaminyl cyclases display significant catalytic proficiency for glutamyl substrates.
    Seifert F; Schulz K; Koch B; Manhart S; Demuth HU; Schilling S
    Biochemistry; 2009 Dec; 48(50):11831-3. PubMed ID: 19921850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of glutaminyl cyclase prevents pGlu-Abeta formation after intracortical/hippocampal microinjection in vivo/in situ.
    Schilling S; Appl T; Hoffmann T; Cynis H; Schulz K; Jagla W; Friedrich D; Wermann M; Buchholz M; Heiser U; von Hörsten S; Demuth HU
    J Neurochem; 2008 Aug; 106(3):1225-36. PubMed ID: 18627432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substrate and inhibitor specificity of glutamine cyclotransferase (QC).
    Gololobov MY; Wang W; Bateman RC
    Biol Chem Hoppe Seyler; 1996 Jun; 377(6):395-8. PubMed ID: 8839986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of human glutaminyl cyclase as a metalloenzyme. Potent inhibition by imidazole derivatives and heterocyclic chelators.
    Schilling S; Niestroj AJ; Rahfeld JU; Hoffmann T; Wermann M; Zunkel K; Wasternack C; Demuth HU
    J Biol Chem; 2003 Dec; 278(50):49773-9. PubMed ID: 14522962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of a new vector system for efficient protein purification in the crystallization of PA5104/ORF from Pseudomonas aeruginosa.
    Lohkamp B; Paterson NG; Lapthorn AJ
    J Struct Biol; 2006 Jul; 155(1):111-3. PubMed ID: 16713297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous spectrometric assays for glutaminyl cyclase activity.
    Schilling S; Hoffmann T; Wermann M; Heiser U; Wasternack C; Demuth HU
    Anal Biochem; 2002 Apr; 303(1):49-56. PubMed ID: 11906150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glutaminyl cyclases from animals and plants: a case of functionally convergent protein evolution.
    Schilling S; Wasternack C; Demuth HU
    Biol Chem; 2008 Aug; 389(8):983-91. PubMed ID: 18979624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purification and partial characterization of coxsackievirus B3 2A protease expressed in Escherichia coli.
    Maghsoudi N; Khodagholi F; Sadjadi M; Zeinodini M; Sabbaghian M
    Int J Biol Macromol; 2008 Oct; 43(3):238-44. PubMed ID: 18590760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substrate specificity of glutaminyl cyclases from plants and animals.
    Schilling S; Manhart S; Hoffmann T; Ludwig HH; Wasternack C; Demuth HU
    Biol Chem; 2003 Dec; 384(12):1583-92. PubMed ID: 14719800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Papaya glutamine cyclotransferase shows a singular five-fold beta-propeller architecture that suggests a novel reaction mechanism.
    Guevara T; Mallorquí-Fernández N; García-Castellanos R; García-Piqué S; Ebert Petersen G; Lauritzen C; Pedersen J; Arnau J; Gomis-Rüth FX; Solà M
    Biol Chem; 2006; 387(10-11):1479-86. PubMed ID: 17081122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer's disease-like pathology.
    Schilling S; Zeitschel U; Hoffmann T; Heiser U; Francke M; Kehlen A; Holzer M; Hutter-Paier B; Prokesch M; Windisch M; Jagla W; Schlenzig D; Lindner C; Rudolph T; Reuter G; Cynis H; Montag D; Demuth HU; Rossner S
    Nat Med; 2008 Oct; 14(10):1106-11. PubMed ID: 18836460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A patent review of glutaminyl cyclase inhibitors (2004-present).
    Coimbra JRM; Salvador JAR
    Expert Opin Ther Pat; 2021 Sep; 31(9):809-836. PubMed ID: 33896339
    [No Abstract]   [Full Text] [Related]  

  • 36. Expression, crystallization and preliminary X-ray crystallographic studies of the outer membrane protein OmpW from Escherichia coli.
    Albrecht R; Zeth K; Söding J; Lupas A; Linke D
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2006 Apr; 62(Pt 4):415-8. PubMed ID: 16582500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and characterization of a recombinant unique acid phosphatase from kidney bean hypocotyl exhibiting chloroperoxidase activity in the yeast Pichia pastoris.
    Yoneyama T; Taira M; Suzuki T; Nakamura M; Niwa K; Watanabe T; Ohyama T
    Protein Expr Purif; 2007 May; 53(1):31-9. PubMed ID: 17258469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression, purification, and characterization of human acetyl-CoA carboxylase 2.
    Kim KW; Yamane H; Zondlo J; Busby J; Wang M
    Protein Expr Purif; 2007 May; 53(1):16-23. PubMed ID: 17223360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and purification of catalytically active human PHD3 in Escherichia coli.
    Fedulova N; Hanrieder J; Bergquist J; Emrén LO
    Protein Expr Purif; 2007 Jul; 54(1):1-10. PubMed ID: 17434750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The soluble Y115E-Y117E variant of human glutaminyl cyclase is a valid target for X-ray and NMR screening of inhibitors against Alzheimer disease.
    DiPisa F; Pozzi C; Benvenuti M; Andreini M; Marconi G; Mangani S
    Acta Crystallogr F Struct Biol Commun; 2015 Aug; 71(Pt 8):986-92. PubMed ID: 26249687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.